The Zuotin-related factor 1, ZRF1, has recently been identified as an epigenetic regulator of gene transcription in stem cells and cancer. During differentiation of human teratocarcinoma cells, ZRF1 promotes transcriptional induction of developmental genes that are repressed by Polycomb complexes. Importantly, ZRF1 has recently been shown to be required for both neural differentiation of embryonic stem cells (ESCs) and for maintenance of neural progenitor cell (NPC) identity. Moreover, a dual role has now emerged for ZRF1 in cancer: on the one hand, ZRF1 plays a crucial role in oncogeneinduced senescence (OIS) by activating the INK4/ARF locus, thus working as a tumor suppressor; on the other hand, ZRF1 promotes leukemogenesis in acute myeloid leukemia (AML) in a Polycomb-independent fashion. Therefore, increasing evidence points to ZRF1 as a novel target for therapy of neurodegenerative diseases and cancer.
Introduction
Epigenetic regulatory mechanisms, such as DNA methylation and histone posttranslational modifications, are essential for maintaining cell identity, and alterations in this process are implicated in multiple diseases, including cancer 1 . Histone modifications play a crucial role in regulating gene expression, both by directly controlling chromatin structure and by acting as docking sites for proteins involved in gene transcription 2 . The Polycomb group of proteins are repressors of gene transcription that work in part by decorating histones with repressive marks (such as di-and trimethylation of histone H3 and mono-ubiquitination of H2A), leading to chromatin compaction and transcription impairment 3 . Organized in multiprotein complexes termed Polycomb repressive complexes 1 and 2 (PRC1 and PRC2), Polycomb proteins play a crucial role in several processes including cell proliferation, X chromosome inactivation, and senescence 4 and are misregulated in several types of cancer 5, 6 . Importantly, PRC1 and PRC2 are master regulators of stem cell identity. In ESCs, PRC1 and PRC2 help to maintain cell identity by repressing developmental genes in all three germ layers (i.e. endoderm, mesoderm, and ectoderm). In line with this, depletion of Polycomb proteins impairs ESC differentiation 2, 4, 7, 8 and leads to embryonic lethality 8 .
The Zuotin-related factor 1, ZRF1 (also termed MPP11, MIDA1, and DNAJC2), has recently emerged as regulator of the expression of Polycomb targets in stem cells and cancer. Indeed, it was reported that ZRF1 promotes Polycomb displacement and transcriptional activation of Polycomb-repressed genes in specific conditions 9, 10 . In this review, recent reports elucidating the role of human/mouse ZRF1 in stem cells and cancer will be discussed 11--14 . Notably, several evidences demonstrate that ZRF1 plays an important role in the control of the expression of master genes and signaling pathways governing stem cell identity and carcinogenesis.
The domain structure of ZRF1 reflects its diverse functions along evolution Several domains have been annotated in the ZRF1 protein (Figure 1 ). The aminoterminal part of the protein, which is conserved from yeast to mammals, contains a DnaJ domain. The DnaJ domain mediates interactions with heat shock proteins and is mainly implicated in protein-chaperone functions associated with ribosomes.
Consistently, the ZRF1 homologue in yeast, Zuotin (also called Zuo1), works as a molecular chaperone associated to ribosomes 15 . Apart from its role as a chaperone, Zuotin can bind to nucleic acids through its DnaJ domain 16, 17 and has been suggested to have a role in transcriptional regulation 18, 19 .
In higher eukaryotes, the protein structure of ZRF1 contains an additional carboxyterminal extension with two SANT domains (Figure 1) . SANT domains are similar to the Myb-DNA binding motif 20 , which is required for Myb proto-oncogene to bind DNA.
Indeed, it has been suggested that ZRF1 can directly bind to DNA 21, 22 . Importantly, SANT domains have been identified in multiple proteins associated to chromatin 20 .
ZRF1 has been shown to have important functions in several model organisms. In the green algae Volvox, the ZRF1 homologue GlsA is essential for asymmetric cell division and germ cell specification [23] [24] [25] . In C. elegans, the ZRF1 homologue dnj-11 plays an important role in asymmetric cell division of neuroblasts by regulating the activity of the Snail-related factor 26, 27 and thus controlling the stress response 28 .
In mammals, ZRF1 (which is widely expressed both in the embryo and in the adult 29 ) was recently found to play a crucial role in epigenetic regulation of gene expression as a chromatin-associated factor. The first indication that ZRF1 could work as chromatinbound protein came from affinity purification assays designed to identify proteins capable of binding to mono-ubiquitinated histone H2A (H2Aub1), a repressive mark deposited by PRC1 10 . In this study, a fraction of the amino-terminal region of ZRF1, annotated as ubiquitin-binding domain (UBD), was found to be sufficient for its binding to H2Aub1 (Figure 1 ). The presence of two SANT domains further supports the role of ZRF1 as a chromatin-bound protein, although their specific functions remain to be addressed. That ZRF1 has a crucial function in transcriptional activation of developmental genes is underscored by its activity as an essential regulator for neural commitment of ESCs 11, 12 (see below). In addition, ZRF1 controls oncogene-induced senescence in a Polycomb dependent manner 14 , while it regulates leukemogenesis through a Polycomb independent mechanism 13 (see below).
ZRF1 regulates gene transcription as a chromatin-associated factor

The role of ZRF1 in stem cells
ZRF1 is required for neural differentiation of mouse ESCs
ZRF1 has been reported to be essential for neural differentiation of mouse ESCs 11, 12 .
ESCs are self-renewing, pluripotent cells, capable of generating all cell types of the embryo in vivo and in vitro 31 . In self-renewing mouse ESCs, ZRF1 binding to chromatin is impaired by its direct interaction with the inhibitor of differentiation 1 (ID1) 12 
ZRF1 is essential for generating and maintaining NPCs
In addition to its essential role for NPC-specification from ESCs (discussed above), the role of ZRF1 in maintaining NPC identity has also been elucidated 11 . NPCs of the embryonic cortex (also termed as radial glial cells) are stem cells capable of selfrenewal and differentiation into neurons and glial cells 37 . Both in cell culture experiments and in vivo, ZRF1 depletion impairs NPC self-renewal and differentiation into neurons, thus making ZRF1 essential for maintenance of NPC identity 11 .
Consistently, the expression of the master regulator of NPCs PAX6, is impaired in ZRF1-depleted NPCs. Moreover, ZRF1 induces the expression of a specific subset of Wnt ligand genes in a polycomb-dependent manner 11 . In consequence of this, ZRF1 Figure 2B ).
Role of ZRF1 in cancer
A link between ZRF1 and cancer was initially suggested by the observation that the region of chromosome 7 where the ZRF1 gene is located (namely, 7q22-31) is commonly altered in several types of human cancers, including breast, prostate, pancreatic, ovarian, gastric, colon, germ cell, glioblastoma, and head and neck malignancies 42 . In line with this, ZRF1 was proposed to have an oncogenic role in head and neck squamous cell carcinoma (HNSCC) 42 . Recent findings regarding the function of ZRF1 in acute myeloid leukemia (AML) and in oncogene-induced senescence (OIS)
suggest that ZRF1 can either work as tumor suppressor or induce carcinogenesis, depending on the cellular context 13, 14 . One attractive hypothesis is that ZRF1 induces senescence in pre-malignant and benign lesions in tissues, whereas it promotes cancer progression in malignant cells, in which senescence-linked pathways are often reduced or completely abolished.
ZRF1 promotes leukemogenesis in AML
Several studies have shown that ZRF1 is overexpressed in leukemia, and specifically, in acute and chronic myeloid leukemia (AML and CML) and in B-cell chronic lymphocytic leukemia (CLL) 43--47 . In line with this ZRF1 overexpression, a proleukemogenic role for ZRF1 has been recently described in AML 13 . In proliferating AML cells, ZRF1 positively regulates proliferation, impairs apoptosis, and blocks differentiation. Consistently, ZRF1 depletion leads to a decrease in cell growth that results in a strong inhibition of leukemogenic potential in vivo upon cell transplantation in mouse xenograft models 13 .
The differentiating agent retinoic acid (RA) induces differentiation of leukemic blasts and is currently being used to treat certain types of AMLs 48, 49 . Interestingly, ZRF1
directly interacts with the RA receptor alpha, RARα, and binds to RA-target genes, suggesting that RARα can recruit ZRF1 to chromatin 13 . Consistently, genome-wide expression profiles indicate that ZRF1 depletion affects nearly half of the RA-regulated transcriptome. Moreover, as previously showed for RARα 49, 50 , ZRF1 has a dual role in transcriptional regulation, working mainly as a transcriptional repressor in the absence of RA and predominantly as a transcriptional activator in the presence of RA. In untreated AML cells, ZRF1 represses RA target genes that regulate proliferation, apoptosis, and differentiation, thus contributing to leukemia development. Consequently, ZRF1 depletion leads to a reactivation of these genes, resulting in an inhibition of leukemogenesis ( Figure 2C ).
Supporting the functional cooperation between ZRF1 and the RA pathway, combining ZRF1 depletion and RA treatment has a synergistic effect in leukemia suppression in vivo 13 . Therefore, ZRF1 inhibition, alone or in combination with RA treatment, represents a novel potential strategy for AML treatment.
Role of ZRF1 in oncogene-induced senescence
In mouse embryonic fibroblasts (MEFs) and in human fetal lung fibroblasts (IMR-90), overexpression of the RAS oncogene leads to the upregulation of ZRF1 expression at both mRNA and protein levels 14 
ii) Specific Polycomb-dependent activity of ZRF1 in stem cells
During differentiation of ESCs, ZRF1 specifically regulates the expression of master neural genes in a Polycomb-dependent manner 11, 12 . Consistently, ZRF1 depletion impairs neural differentiation but does not affect differentiation toward mesendodermal lineages 11 . In contrast to the broad role of Polycomb complexes as regulators of ESC differentiation into all three germ layers 8 , ZRF1 function in ESCs is restricted to NPC specification 11 . ChIP sequencing analysis revealed that about 30% of ZRF1 targets in
NPCs overlap with Polycomb targets in ESCs, with these common targets representing about 10% of all Polycomb targets in ESCs. As expected, Gene Ontology analysis revealed that these common genes are involved in neurogenesis 11 . However, a significant fraction of Polycomb target genes involved in neurogenesis is not bound by ZRF1 in NPCs, indicating that: 1) ZRF1 specifically regulates a subset of genes involved in neurogenesis; and 2) Polycomb possesses a ZRF1-independent function in neurogenesis. Therefore, further investigation of ZRF1 function might unveil novel Polycomb functions in stem cells and development. As discussed above, deciphering how ZRF1 is specifically recruited to neural genes will help to understand this process.
In NPCs, ZRF1 regulates Wnt signaling activity by inducing the expression of a specific subset of Wnt ligand genes in a Polycomb-dependent manner 11 . Interestingly, ZRF1-bound Wnt ligands are up-regulated in NPCs as compared to ESCs, suggesting that they exert a unique function in NPCs. Therefore, further investigation of the role of ZRF1 might unveil novel cell-specific functions of Polycomb targets.
iii) Function of ZRF1 as a transcriptional activator and repressor
Whether the effect of ZRF1 as a transcriptional activator is only due to the removal of H2Aub1 mark or also involves direct transcriptional activation needs to be addressed. In this regard, increasing evidence (Demajo et al., unpublished) suggests that ZRF1 might interact with two different complexes that are known to participate in transcriptional activation: the FACT complex, which works as a histone chaperone to facilitate nucleosome remodeling during transcriptional elongation, 54 and the MLL complex, which trimethylates H3K4, a mark associated with transcriptional initiation. 3 Understanding whether ZRF1 functionally cooperates with the FACT complex and/or the MLL complex will help to answer the question of how it functions as a transcriptional activator.
In AML cells, ZRF1 can not only activate but also repress transcription 13 . Specifically, ZRF1 represses RA target genes by regulating basal histone acetylation levels.
Interestingly, RARα-mediated repression also involves the regulation of histone acetylation, and the histone deacetylases (HDACs) are fundamental components of the RARα-associated corepressor complexes 49 . Further investigation is required to understand to which extent ZRF1 is involved in this complex regulatory mechanism.
Additionally, the molecular mechanisms that determines whether ZRF1 works as a transcriptional activator or repressor in different genes and cellular contexts also need to be elucidated.
iv) Downstream targets of ZRF1
A more extensive knowledge about the downstream targets of ZRF1 could help to develop novel therapeutic strategies in cancer and disease. In AML, RA and ZRF1 cooperate to regulate gene transcription 13 
